Lucid Diagnostics (Karnataka) Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 10-12-2024
- Paid Up Capital ₹ 3.45 Cr
as on 10-12-2024
- Company Age 13 Year, 5 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 9.65 M
as on 10-12-2024
- Satisfied Charges ₹ 13.07 Cr
as on 10-12-2024
- Revenue -45.87%
(FY 2020)
- Profit -9.49%
(FY 2020)
- Ebitda -41.36%
(FY 2020)
- Net Worth -112.86%
(FY 2020)
- Total Assets -31.38%
(FY 2020)
About Lucid Diagnostics (Karnataka)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.45 Cr.
The company currently has active open charges totaling ₹9.65 M. The company has closed loans amounting to ₹13.07 Cr, as per Ministry of Corporate Affairs (MCA) records.
Chakravarthi Gutta, Prasanna Nyapathi, and Sai Reddy serve as directors at the Company.
- CIN/LLPIN
U85100KA2011PTC059682
- Company No.
059682
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jul 2011
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Lucid Diagnostics (Karnataka)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chakravarthi Gutta  | Director | 22-Jul-2011 | Current |
| Prasanna Nyapathi | Director | 08-Jan-2015 | Current |
| Sai Reddy | Director | 05-Dec-2014 | Current |
Financial Performance of Lucid Diagnostics (Karnataka).
Lucid Diagnostics (Karnataka) Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 45.87% decrease. The company also saw a slight decrease in profitability, with a 9.49% decrease in profit. The company's net worth observed a substantial decline by a decrease of 112.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lucid Diagnostics (Karnataka)?
In 2020, Lucid Diagnostics (Karnataka) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Arete Institute Of Medical Sciences Private LimitedActive 3 years 5 months
Chakravarthi Gutta is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 25 Oct 2019 | ₹4.65 M | Open |
Others Creation Date: 25 Jan 2017 | ₹5.00 M | Open |
Others Creation Date: 31 Mar 2018 | ₹1.40 Cr | Satisfied |
How Many Employees Work at Lucid Diagnostics (Karnataka)?
Lucid Diagnostics (Karnataka) has a workforce of 1 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lucid Diagnostics (Karnataka), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lucid Diagnostics (Karnataka)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
